Skip to main content
Year archive

STARSOURCE MULTITRADE LIMITED — 2020 filings

All 33 regulatory filings released by STARSOURCE MULTITRADE LIMITED (506365) in 2020, sourced directly from the official regulator.

33 Filings
2020 Period
2020 filings (33)
Filing Released Lang
Intimation of Closure of Trading Window for the quarter ended 31.12.2020
Regulatory Filings
2020-12-30 English
DISCLOSURE OF EVENTS OR INFORMATION AS PER REG. 30 AND 68(2) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 -SAD DEMISE OF SHRI. SHREENIWAS SOMANI, CEO AND ....
Regulatory Filings
2020-11-11 English
Submission of Un-Audited Financial Results for the quarter and half year ended 30.09.2020
Regulatory Filings
2020-10-19 English
AUTHORISATION FOR DISCLOSURE OF EVENTS OR INFORMATION AS PER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (LODR)
Regulatory Filings
2020-10-19 English
Submission of Outcome of Board Meeting held on 19/10/2020 at 04 p.m.
Regulatory Filings
2020-10-19 English
Submission of Certificate pursuant to Regulation 40(9) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, issued by M/s. HS Associates, Practising Company Secretary ....
Regulatory Filings
2020-10-15 English
Submission of Certificate pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter and half year ended ....
Regulatory Filings
2020-10-08 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2020 ,inter alia, to consider and approve Dear Sirs, ....
Regulatory Filings
2020-10-08 English
Submission of Compliance Certificate Pursuant to the Regulation 7(3) of Securities Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015 for Quarter ....
Regulatory Filings
2020-10-06 English
Pursuant to regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, we submit herewith the details regarding the voting results of the business transacted at the ....
Regulatory Filings
2020-10-01 English
Intimation of Closure of Trading Window for the quarter ended 30.09.2020
Regulatory Filings
2020-09-30 English
Disclosure of events pursuant to Regulation 30(2) Schedule III - Part A - A (13) of SEBI (Listing Regulations & Disclosure Requirements), 2015 - Summary of the Proceedings of the Seventy ....
Regulatory Filings
2020-09-29 English
Submission of Annual Report for the financial year 2019-2020 as per Regulation 34 of SEBI(LODR), 2015
Regulatory Filings
2020-08-20 English
Dear Sirs, This is to inform you that Register of Members (Share Transfer Book) will be closed pursuant to the Regulation 42 (2) to (4) of SEBI (Listing Obligations And Disclosure ....
Regulatory Filings
2020-08-18 English
Submission of Un-Audited Financial Results for the quarter ended 30.06.2020
Regulatory Filings
2020-08-18 English
Submission of Outcome of Board Meeting held on 18.08.2020
Regulatory Filings
2020-08-18 English
Purpose of the meeting has been revised
Regulatory Filings
2020-08-11 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/08/2020 ,inter alia, to consider and approve Dear Sirs, ....
Regulatory Filings
2020-08-10 English
Submission of Revised Audited Financial Results for the quarter and year ended 31.03.2020
Regulatory Filings
2020-08-06 English
Submission of Certificate received from M/s. Purva Registry (India) Private Limited, Registrar and Share Transfer Agent (RTA) of our Company as per regulation 74(5) of the SEBI (Depositories ....
Regulatory Filings
2020-07-08 English
This is to inform you that as per the Company''s Code of Conduct to regulate, monitor and report trading by insiders (''Code''), the Trading Window for dealing in the securities of the ....
Regulatory Filings
2020-06-30 English
Submission of Audited Financial Results for the quarter and year ended 31.03.2020
Regulatory Filings
2020-06-26 English
Outcome of Board Meeting held on 26.06.2020
Regulatory Filings
2020-06-26 English
Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, please find enclosed herewith disclosure on material impact of COVID-19 pandemic on the Company.
Regulatory Filings
2020-06-23 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2020 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2020-06-16 English
We submit herewith the confirmation certificate received from M/s Purva Sharegistry (India) Private Limited, Registrar and Share Transfer Agent (RTA) as per regulation 74(5) of the SEBI ....
Regulatory Filings
2020-05-07 English
Please find enclosed the certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ....
Regulatory Filings
2020-05-05 English
Pursuant to Regulation 40(10) of the Listing Regulations, please find enclosed herewith a certificate issued by M/s. S. K. Jain & Co., Practicing Company Secretary, Mumbai for the half ....
Regulatory Filings
2020-05-04 English
We would like to inform you that as per the Company''s Code of Conduct formulated pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for trading in ....
Regulatory Filings
2020-03-31 English
Submission of Un-Audited Financial Results for the quarter ended 31.12.2019
Regulatory Filings
2020-01-28 English
Outcome of Board Meeting for the quarter ended 31.12.2019
Regulatory Filings
2020-01-28 English
Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2019
Regulatory Filings
2020-01-08 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2020 ,inter alia, to consider and approve Intimation of meeting ....
Regulatory Filings
2020-01-03 English